Colgate-Palmolive (CL) Tops Q1 Earnings and Revenue Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.86 per share a year ago.
Colgate-Palmolive Tops Q1 Estimates, Lifts Full-Year Net Sales Outlook
Colgate-Palmolive (CL) on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, although it lowered its profit projection.
Colgate-Palmolive Cuts Earnings Outlook on Tariffs
Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.
Colgate Gears Up for Q1 Earnings: Here's What You Should Know
CL's first-quarter results are likely to show sales pressure from macro headwinds, partially offset by margin gains from pricing and productivity.
Unlocking Q1 Potential of Colgate-Palmolive (CL): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Colgate-Palmolive (CL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
A Historic Brand, A Fresh Approach: Inside Colgate-Palmolive's Machine
Colgate-Palmolive achieved over $20 billion in revenue in 2024, driven by strong brand identity, operational discipline, and a diversified product portfolio across Oral Care, Personal Care, Home Care, and Pet Nutrition. The company maintained profitability despite inflation, with a 14.4% margin, and continued to invest in marketing and R&D, enhancing brand differentiation and price stability. Financially robust, Colgate-Palmolive showed significant revenue and margin growth, generating record free cash flow, and is well-positioned for 2025 with a "Buy" rating and a target share price of $100.08.
Colgate-Palmolive (CL) Reports Next Week: What Awaits?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate's Pricing & Productivity Efforts Progress Well: Apt to Hold?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate's Path to Sustainable Growth: Innovation & Digital Expansion
CL drives long-term growth through innovation, digital expansion and sustainability while tackling market challenges with strategic investments and efficiency.
The Smartest Dividend Stocks to Buy With $350 Right Now
Riskier assets like growth and technology stocks have enjoyed a strong run since early 2023. However, some uncertainty has begun clouding the stock market's outlook.
4 Consumer Product Stocks to Keep an Eye on Despite Market Challenges
The Zacks Consumer Products - Staples industry is navigating a tough consumer environment and elevated SG&A costs. Nevertheless, PG, CL, KMB and CLX are leveraging innovations to drive growth.
Colgate-Palmolive: A Defensive Play To Position Against A Potential Recession
Fears of a recession make investors actively reposition their portfolios, and defensive companies such as Colgate-Palmolive have non-cyclical characteristics. The company outperforms its peers in terms of profitability, with a strong gross profit margin of over 60% and a high return on total capital of 27.9%. CL stock is valued fairly, with a shareholder value yield above its historical average and a decent price-to-earnings multiple of 25.6x.
